Report overview
Rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children. The vaccines prevent 15?34% of severe diarrhea in the developing world and 37?96% of severe diarrhea in the developed world. The vaccines decrease the risk of death among young children due to diarrhea. Immunizing babies decreases rates of disease among older people and those who have not been immunized.
The World Health Organization (WHO) recommends that rotavirus vaccine be included in national routine vaccinations programs, especially in areas where the disease is common. This should be done along with promoting breastfeeding, handwashing, clean water and good sanitation. It is given by mouth and requires two or three doses. It should be given starting around six weeks of age.
The vaccines are safe. This includes their use in people with HIV/AIDS. An earlier vaccine that is no longer used was linked to intussusception, but the current versions are not clearly linked. Due to a potential risk they are not recommended in babies who have had intussusception. The vaccines are made from weakened rotavirus.
The vaccine first became available in the United States in 2006. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between US$6.96 and $20.66 per dose as of 2014.In the United States it is more than US$200. As of 2013 there are two types of vaccine available globally, Rotarix and RotaTeq. Others are used in some countries.
This report aims to provide a comprehensive presentation of the global market for Rotavirus Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rotavirus Vaccines. This report contains market size and forecasts of Rotavirus Vaccines in global, including the following market information:
Global Rotavirus Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Rotavirus Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Rotavirus Vaccines companies in 2022 (%)
The global Rotavirus Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Rotarix Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Rotavirus Vaccines include Bharat Biotech, Merck & Co., Inc, GlaxoSmithKline plc, Lanzhou Institute of Biological and Bharat Biotech International Limited, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Rotavirus Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rotavirus Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Rotavirus Vaccines Market Segment Percentages, by Type, 2022 (%)
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Others
Global Rotavirus Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Rotavirus Vaccines Market Segment Percentages, by Application, 2022 (%)
Adult
Pediatric
Global Rotavirus Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Rotavirus Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rotavirus Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Rotavirus Vaccines revenues share in global market, 2022 (%)
Key companies Rotavirus Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Rotavirus Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bharat Biotech
Merck & Co., Inc
GlaxoSmithKline plc
Lanzhou Institute of Biological
Bharat Biotech International Limited
Outline of Major Chapters:
Chapter 1: Introduces the definition of Rotavirus Vaccines, market overview.
Chapter 2: Global Rotavirus Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Rotavirus Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rotavirus Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Rotavirus Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
